IMAPAC

Our esteemed speakers are gearing up to take the stage at the Vaccine World Asia Congress 2024 - South East Asia Focused, happening on the 6th and 7th of November at the Amari Bangkok, Thailand! Don’t miss out—explore the key topics they’ll be covering by viewing our brochure here: https://lnkd.in/gPDnv6-g. Join us for insightful discussions on the latest advancements in vaccine development across South East Asia, and connect with leading regional partners. Interested in attending as a delegate or bringing a group? Email us at biologicsworld@imapac.com for a special discount!

📣1 WEEK TO GO! Advance your knowledge on all things vaccine-related and network with 300+ industry experts at South East Asia's ONLY vaccine conference in the region from discovery to delivery! Register here: https://lnkd.in/gyhgPJAs Join leaders from Singapore, Thailand, Malaysia, Indonesia, Vietnam, and more to discuss innovative manufacturing processes and cutting-edge technologies which will help transform innovative concepts into actionable solutions, accelerate research initiatives, and bolster manufacturing capabilities to revolutionize vaccine development in the region! Interested in attending as a delegate or bringing a group? Email us at biologicsworld@imapac.com for a special discount! Event Details: 📅 Date: 6th and 7th November 📍 Location: Amari Bangkok, Thailand

Recognising the 𝐭𝐫𝐚𝐢𝐥𝐛𝐥𝐚𝐳𝐞𝐫𝐬 𝐚𝐧𝐝 𝐠𝐚𝐦𝐞-𝐜𝐡𝐚𝐧𝐠𝐞𝐫𝐬 𝐢𝐧 𝐍𝐨𝐫𝐝𝐢𝐜𝐬, we celebrate the leaders shaping the future of biomanufacturing at the 🌟 𝐍𝐨𝐫𝐝𝐢𝐜𝐬 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐄𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞 𝐀𝐰𝐚𝐫𝐝𝐬 2025 🌟 From groundbreaking R&D advancements to disruptive technologies and best-in-class manufacturing practices, this is where the exceptional minds propelling the industry forward are honoured. 𝐉𝐨𝐢𝐧 𝐮𝐬 𝐢𝐧 𝐜𝐞𝐥𝐞𝐛𝐫𝐚𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐯𝐢𝐬𝐢𝐨𝐧𝐚𝐫𝐢𝐞𝐬 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐛𝐢𝐨𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐛𝐲 𝐧𝐨𝐦𝐢𝐧𝐚𝐭𝐢𝐧𝐠 outstanding companies or individuals who have made significant contributions to the biopharmaceutical industry within the following key categories: - Process Development & Manufacturing Excellence - Innovation Excellence  - Nordic Excellence - Individual Excellence - Lifetime Achievement ✨ Submit your nomination here: https://lnkd.in/eri7Ajv4  📅 Deadline for nominations: 30 November 2024 🔗 For more information on how to nominate and the selection process, have a look at the awards handbook: https://lnkd.in/eqJfixg8 #ImagineYourImpact #Biopharma #Manufacturing #Biomanufacturing #IMAPAC #Nordics #Award #Nomination #NordicsBiopharmaExcellenceAwards #IMAPACAwards #BioPharmaAwards

We are thrilled to introduce Dr. Ajay Singh as an esteemed speaker at the Vaccine World Asia Congress 2024 - South East Asia Focused --- the region's only vaccine conference from discovery to delivery! Find out more about the event here: https://lnkd.in/gPDnv6-g Dr. Singh, a skilled molecular biologist and biochemist earned his doctorate from South Campus, Delhi University, India.  Since joining Gennova in 2013, Dr. Singh has expanded his expertise in the area of mRNA vaccines, cell therapy, gene therapy, biotherapeutics, and antibody discovery. His significant contributions to mRNA design, development, and manufacturing culminated in India's first fully indigenous self-amplifying thermostable mRNA vaccine, GEMCOVAC ® -19, followed by an Omicron-specific heterologous booster, GEMCOVAC ® -OM. Presently, he is working diligently on expanding the mRNA platform for various vaccines and cell/gene therapy products. Take the opportunity to meet him and hear his revered insights at Vaccine World Asia Congress 2024 - South East Asia Focused which will take place on the 6th and 7th of November in Bangkok, Thailand! Interested in attending as a delegate or bringing a group? Email us at biologicsworld@imapac.com for a special discount!

[BMA2025] It’s our pleasure to welcome Pfanstiehl, Inc. as a Silver 𝐒𝐩𝐨𝐧𝐬𝐨𝐫 𝐟𝐨𝐫 𝐭𝐡𝐞 𝟏𝟐𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐀𝐬𝐢𝐚 𝟐𝟎𝟐𝟓! Pfanstiehl, Inc. is the market leader of high purity, low endotoxin, low metal excipients for biologics, biosimilars, vaccines, cell culture media and injectable (liquid and lyophilized) formulations and supplies its products to nearly all leading global biopharmaceutical companies. Pfanstiehl was founded in 1919 and currently celebrating its 103rd anniversary year in 2022. Pfanstiehl is headquartered at Waukegan, IL, USA and has diverse global technical support team across the globe in USA, Europe & APAC. Pfanstiehl has manufactured parenteral grade excipients for more than 50 years, and Pfanstiehl’s high purity, low endotoxin and low metal excipient products are known as “best in class” due to their high characterization, performance, consistency, and quality attributes. Pfanstiehl’s excipients are critical components in the majority of the global blockbuster biopharmaceutical drugs and vaccines including majority of the Covid -19 vaccines that were administered globally. For more information about Pfanstiehl Inc, and their products and solutions, please contact them at cs@pfanstiehl.com or visit www.Pfanstiehl.com Join us for an exciting opportunity at Asia’s largest bioprocessing event—𝟏𝟐𝐭𝐡 𝐀𝐧𝐧𝐮𝐚𝐥 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐬 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐀𝐬𝐢𝐚 𝟐𝟎𝟐𝟓, 𝐭𝐚𝐤𝐢𝐧𝐠 𝐩𝐥𝐚𝐜𝐞 𝐨𝐧 𝟏𝟐𝐭𝐡-𝟏𝟑𝐭𝐡 𝐌𝐚𝐫𝐜𝐡 𝟐𝟎𝟐𝟓 𝐚𝐭 𝐭𝐡𝐞 𝐒𝐚𝐧𝐝𝐬 𝐄𝐱𝐩𝐨 & 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐂𝐞𝐧𝐭𝐫𝐞, 𝐒𝐢𝐧𝐠𝐚𝐩𝐨𝐫𝐞. 🎟 Register Here: https://lnkd.in/etTtSXHe #Biologics #Biomanufacturing #Biopharma #Excipients #HighPurity #LowEndotoxin #VaccineProduction #CellCultureMedia #Pfanstiehl #GlobalBiotech #COVID19Vaccines #HealthcareInnovation #BiotechConference #SingaporeEvents #BiologicsAsia2025 #IMAPAC

Join Tofflon Group’s Exclusive Workshop at the Vaccine World Asia Congress 2024 - Focused on Southeast Asia! Register by November 4th to guarantee your spot* - https://lnkd.in/gRDPBd6M Dive into the latest trends and innovations in vaccine manufacturing across Southeast Asia at this comprehensive workshop hosted by Tofflon! Our expert speakers will explore cutting-edge topics and industry insights tailored to the needs of the SEA region. Meet and Learn from Our Distinguished Speakers: 1. Dr Zhao Chunhua, General Manager of the Engineering Division, Tofflon Group 2. Claire Su Yin Chong, Technical Application Manager, Tofflon Singapore 3. Yen Lu Toh, Regional Sales Manager, Tofflon Southeast Asia Hub 4. RAVI GANAPATHY, Director CMC & R&D, Hilleman Laboratories, Singapore 5. Akrim Jantaraprapa, Associate Principal I Pharma & Lifescience Consulting, IQVIA, Thailand Network with industry experts, gain practical knowledge, and stay ahead of the curve. Don’t wait—register today to reserve your place! https://lnkd.in/gRDPBd6M Event Details: Date: 5th November 2025 Location: Amari Bangkok, Thailand Time: 1 PM - 5.30 PM * Registrations will be vetted before confirmation.

We're excited to introduce Professor Thomas Preiss, a leading voice in RNA biology, as a distinguished speaker at the upcoming ANZ Biologics Festival! As Co-Head of the Division of Genome Sciences & Cancer at The John Curtin School of Medical Research and inaugural Director of the ANU Shine-Dalgarno Centre for RNA Innovation, Professor Preiss has made pioneering contributions to our understanding of #geneexpression and translation initiation in eukaryotes. His groundbreaking work has shaped the field, driving advancements in RNA research and its implications for health and disease.    Australia and New Zealand’s ONLY Conference on Biologics: Covering Discovery to Delivery  📅 Save the Date: 4th – 5th February 2025   📍 Location: Crown Promenade, Melbourne, Australia     🔗 Learn more and register: https://lnkd.in/eVspKptm     #ABF2025 #ANZBioPharma #Biologics #CellandGeneTherapy #RNATherapeutics #NextGenCellTherapeutics 

🚀 Exciting News! Sebastian Schneider, Head of E2E Cell & Gene Value Chain at Roche, will deliver the opening keynote at 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝟮𝟬𝟮𝟱! He’ll dive into 𝘾𝙤𝙢𝙢𝙚𝙧𝙘𝙞𝙖𝙡𝙞𝙨𝙞𝙣𝙜 𝘾𝙚𝙡𝙡 & 𝙂𝙚𝙣𝙚 𝙏𝙝𝙚𝙧𝙖𝙥𝙞𝙚𝙨 𝙞𝙣 𝙂𝙡𝙤𝙗𝙖𝙡 𝙈𝙖𝙧𝙠𝙚𝙩𝙨, covering: 🌍 Navigating complex regulatory landscapes for global CGT commercialisation across diverse markets 🏭 Developing scalable manufacturing and distribution strategies to meet global demand 🤝 Building strategic partnerships to enhance market access and adoption worldwide This keynote will set the stage for an impactful event, inspiring new strategies for making CGT innovations available to those who need them most. Join us to gain insights from a leader at the forefront of CGT innovation! Get more info and register here: https://lnkd.in/eZpaqnjm #ImagineYourImpact #CGTMS2025 #CellAndGeneTherapyManufacturing #Roche #CGT

We are thrilled to introduce RAVI GANAPATHY as an esteemed speaker at the Vaccine World Asia Congress 2024 - South East Asia Focused --- the region's only vaccine conference from discovery to delivery! Find out more about the event here: https://lnkd.in/gPDnv6-g Ravi has over 30 years of professional experience in biotech research and the vaccine industry, including 26 years specifically in the vaccine sector at international institutes in India, South Korea, and Singapore. He has held various leadership roles, notably as Head of Vaccine Development at the International Vaccine Institute in Seoul and Vice President of Manufacturing Science at Biological E. Ltd. His expertise spans the development and manufacturing of recombinant, bacterial, conjugate, and viral vaccines, with hands-on experience in R&D, production, and quality assurance, adhering to GLP and GMP standards. Ravi has been instrumental in vaccine life-cycle management, technology transfers, and the development of India’s first cell culture-derived Pandemic H1N1 Influenza vaccine. He has collaborated with international organizations like PATH and BMGF, served as an Adjunct Professor at Yonsei University, and is currently a consultant for the IVI-led Biomanufacturing Workforce Training Program. Ravi holds an international patent for a novel adjuvant preparation process, has published 11 papers, and has a PhD in Biotechnology, an MSc in Medical Entomology, and a BSc in Medical Laboratory Technology, along with extensive experience speaking at international conferences. Take the opportunity to meet him and hear his revered insights at Vaccine World Asia Congress 2024 - South East Asia Focused which will take place on the 6th and 7th of November in Bangkok, Thailand! Interested in attending as a delegate or bringing a group? Email us at biologicsworld@imapac.com for a special discount!

We are incredibly excited to welcome Prasen Adya as an expert speaker at the Vaccine World Asia Congress 2024 - SEA Focused --- the region's only vaccine conference from discovery to delivery! Find out more about the event here: https://lnkd.in/gPDnv6-g Prasen serves as the Deputy Director at the Serum Institute of India, where he is responsible for overseeing business operations in the Southeast Asia region, including Nepal, Bhutan, Australia, and New Zealand. With over three decades of leadership experience in the pharmaceutical and biotech industries, he has a proven track record in country general management, accelerated market access, and managing country operations and regulatory progress. Since joining the Serum Institute of India in 2005, he has played a pivotal role in driving growth and innovation within the organization. Take the opportunity to meet him and hear his revered insights at Vaccine World Asia Congress 2024 - South East Asia Focused which will take place on the 6th and 7th of November in Bangkok, Thailand! Interested in attending as a delegate or bringing a group? Email us at biologicsworld@imapac.com for a special discount!